Clinical Cohort Study of DHA in Neurodevelopmental Disorders
Autism or Autistic Traits
About this trial
This is an interventional basic science trial for Autism or Autistic Traits
Eligibility Criteria
Inclusion Criteria: Children who were admitted to the Department of Child Care and Developmental Behavior of our hospital and diagnosed as ASD by developmental pediatricians according to the diagnostic criteria of DSM-5. Willing to participate in the study, consume the treatment and perform all measurements including developmental or cognitive testing, blood drawing, anthropometry and questionnaires etc. Informed consent signed by parent or caregiver. Exclusion Criteria: Children with immune deficiency. Children with major organ malformations (congenital heart disease, nervous system tumors, obvious structural abnormalities of the nervous system, digestive tract malformations, etc.) Have a history of DHA allergy or obvious adverse reactions
Sites / Locations
- Children's Hospital of Fudan University
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
ASD active
ASD placebo
Dietary Supplement: Docosahexaenoic acid 200mg DHA once, twice a day
Dietary Supplement: Placebo dietary intervention Vitamin D 400IU once, once a day